Coronavirus | WHO rejects SII proposal to extend Covishield shelf life from 6 to 9 months
Updated:
Updated:
April 08, 2021 22:33 IST
The move comes even as India s drug regulator has extended Covishield s shelf life from six to nine months from its manufacturing date
Share Article
The move comes even as India s drug regulator has extended Covishield s shelf life from six to nine months from its manufacturing date
The WHO has rejected Serum Institute of India s proposal seeking extension of the shelf life of Oxford-AstraZeneca COVID-19 vaccine, Covishield, from six to nine months, citing insufficient data, sources said. The WHO has also sought a meeting with Drugs Controller General of India (DCGI) to discuss the matter, they said.
FPJ Edit: Onus on Centre to step up vaccination supplies
The second surge amidst the ongoing vaccination drive is a matter of huge concern. Even before there could be a return to the pre-Covid-19 normal, the country is again in the grip of a fresh spurt in infections. More than one lakh new cases were recorded in the last 24 hours alone till early Wednesday, spotlighting the renewed challenge the health authorities are up against. The virus seems to be under no oneâs control. Lest you think that it is peculiar to India alone, do note that several European nations are in a much worse state. But that, of course, is no comfort. We have to wage our own battle against the biggest health crisis this century.
UK To Offer AstraZeneca Alternative To Under-30s Over Blood Clot Concerns UK To Offer AstraZeneca Alternative To Under-30s Over Blood Clot Concerns Adults who are aged 18 to 29 years old who do not have an underlying health condition. should be offered an alternative Covid-19 vaccine in preference to the AstraZeneca vaccine, Wei Shen Lim of the Joint Committee on Vaccination and Immunisation, said at a press conference.
Most people under 30 should be offered an alternative to AstraZeneca jab if possible: UK
London:
A government committee in the UK advising on coronavirus vaccinations has said people under the age of 30 should be offered an alternative to the AstraZeneca vaccine, after 19 people died in the country from rare blood clots after receiving the jab. Altogether, 79 such cases have been reported in the country.
Coronavirus: India pins its hopes on vaccines to stop COVID case surge
India is experiencing a record-breaking rise in new coronavirus cases as health authorities scramble to step up a nationwide vaccination campaign.
India is increasing COVID vaccinations amid a potential third wave of infections
India on Sunday registered more than 100,000 new COVID cases in 24 hours for the first time since the pandemic began, as a new wave of infections threatens to overwhelm the country s health care system.
Sunday s spike makes India the only country besides the United States to record a six-digit number of new COVID cases in a 24-hour period.
Covaxin The More-preferred Vaccine Among Indians, Says Survey ibtimes.co.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.co.in Daily Mail and Mail on Sunday newspapers.